Pro Dex (PDEX) EBT Margin (2010 - 2026)

Pro Dex (PDEX) posted EBT Margin of 26.77% for Q1 2026, up 70.62% sequentially from 15.69% in Q4 2025, and up 62.0% YoY from 16.52% in Q1 2025.

Pro Dex (PDEX) EBT Margin (2010 - 2026) Analysis & Trends

Pro Dex has reported EBT Margin for 14 years, with the latest figure at 26.77% in Q1 2026.

Quarterly EBT Margin rose 62.0% year-over-year to 26.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.56% (up 224.0% YoY) and the FY2025 annual result came in at 18.11%, up 1322.0% from the prior year.
EBT Margin grew to 26.77% in Q1 2026 per PDEX's latest filing, from 15.69% in the prior quarter.
Over five years, EBT Margin peaked at 33.58% in Q3 2025 and troughed at 6.94% in Q3 2023.
A 5-year average of 16.27% and a median of 15.69% in 2025 frame the typical range for EBT Margin.
The sharpest annual moves came in 2023 and 2024: EBT Margin plunged 2837 bps in 2023, then jumped 2923 bps in 2024.
Over 5 years, EBT Margin stood at 33.29% in 2022, then plunged by 85 bps to 4.93% in 2023, then surged by 213 bps to 15.4% in 2024, then climbed by 2 bps to 15.69% in 2025, then surged by 71 bps to 26.77% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 26.77%, 15.69%, and 33.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	36.46%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	11.12%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	-1.63%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	32.40%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	3.06%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	20.65%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.89%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-4.48%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	5.34%
10	Pro Dex	215.72 Mn	204.74 Mn	6.13 Mn	26.77%

Download Data